Share this post on:

Name:

Ivuxolimab Biosimilar, Anti-CD134/TNFRSF4/OX40

Host species:

Homo sapiens

Species reactivity:

Human

Form:

solution

Storage buffer:

0.01M PBS, pH 7.4.

Concentration:

1 mg/ml

Purity:

>95%.category:Monoclonal

Isotype:

IgG2-kappa

Applications:

Biosimilar

For research use only. We do not sell to patients.

Target:

ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

Purification:

Protein A/G purified from cell culture supernatant.

Endotoxin level:

Please contact with the lab for this information.

Expression system:

MammalianP43489https://www.ncbi.nlm.nih.gov/protein/P43489

Stability and Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4C short term

1-2 weeks:

.Store at -20 C 12 months. Store at -80C long term.

Alternative Names:

PF-04518600, CAS: 2225940-98-5Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Mouse IgG H&L
ERK2 Antibody
Chk2 Antibody: Chk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to Chk2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Share this post on:

Author: signsin1dayinc